Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
How to buy Co-Diagnostics stock
Own Co-Diagnostics stock in just a few minutes.
Co-Diagnostics, Inc is a diagnostics & research business based in the US. Co-Diagnostics shares (CODX) are listed on the NASDAQ and all prices are listed in US Dollars. Co-Diagnostics employs 39 staff and has a trailing 12-month revenue of around USD$25.7 million.
How to buy shares in Co-Diagnostics
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Co-Diagnostics Find the stock by name or ticker symbol: CODX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Co-Diagnostics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Co-Diagnostics, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Co-Diagnostics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Co-Diagnostics share price
Use our graph to track the performance of CODX stocks over time.Co-Diagnostics shares at a glance
Information last updated 2020-09-25.
| 52-week range | USD$0.8463 - USD$30.99 |
|---|---|
| 50-day moving average | USD$14.6927 |
| 200-day moving average | USD$15.4462 |
| Wall St. target price | USD$35.33 |
| PE ratio | 68.9 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$0.351 |
Compare trading platforms
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Co-Diagnostics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Co-Diagnostics price performance over time
Historical closes compared with the last close of $N/A
| 1 week (2020-09-17) | -100.00% |
|---|---|
| 1 month (2020-08-27) | -100.00% |
| 3 months (2020-06-26) | -100.00% |
| 6 months (2020-03-26) | -100.00% |
| 1 year (2019-09-26) | -100.00% |
|---|---|
| 2 years (2018-09-26) | -100.00% |
| 3 years (2017-09-26) | -100.00% |
| 5 years (2015-09-23) | N/A |
Is Co-Diagnostics under- or over-valued?
Valuing Co-Diagnostics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Co-Diagnostics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Co-Diagnostics's P/E ratio
Co-Diagnostics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 69x. In other words, Co-Diagnostics shares trade at around 69x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Co-Diagnostics's EBITDA
Co-Diagnostics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$8.1 million.
The EBITDA is a measure of a Co-Diagnostics's overall financial performance and is widely used to measure a its profitability.
Co-Diagnostics financials
| Revenue TTM | USD$25.7 million |
|---|---|
| Operating margin TTM | 31.02% |
| Gross profit TTM | USD$102,543 |
| Return on assets TTM | 23.91% |
| Return on equity TTM | 42.38% |
| Profit margin | 31.42% |
| Book value | $1.192 |
| Market capitalisation | USD$407 million |
TTM: trailing 12 months
Shorting Co-Diagnostics shares
There are currently 7.8 million Co-Diagnostics shares held short by investors – that's known as Co-Diagnostics's "short interest". This figure is 18% up from 6.6 million last month.
There are a few different ways that this level of interest in shorting Co-Diagnostics shares can be evaluated.
Co-Diagnostics's "short interest ratio" (SIR)
Co-Diagnostics's "short interest ratio" (SIR) is the quantity of Co-Diagnostics shares currently shorted divided by the average quantity of Co-Diagnostics shares traded daily (recently around 4.3 million). Co-Diagnostics's SIR currently stands at 1.83. In other words for every 100,000 Co-Diagnostics shares traded daily on the market, roughly 1830 shares are currently held short.
However Co-Diagnostics's short interest can also be evaluated against the total number of Co-Diagnostics shares, or, against the total number of tradable Co-Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Co-Diagnostics's short interest could be expressed as 0.28% of the outstanding shares (for every 100,000 Co-Diagnostics shares in existence, roughly 280 shares are currently held short) or 0.2794% of the tradable shares (for every 100,000 tradable Co-Diagnostics shares, roughly 279 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Co-Diagnostics.
Find out more about how you can short Co-Diagnostics stock.
Co-Diagnostics share dividends
We're not expecting Co-Diagnostics to pay a dividend over the next 12 months.
Co-Diagnostics share price volatility
Over the last 12 months, Co-Diagnostics's shares have ranged in value from as little as $0.8463 up to $30.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Co-Diagnostics's is -1.6708. This would suggest that Co-Diagnostics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Co-Diagnostics has bucked the trend.
Co-Diagnostics overview
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.
Frequently asked questions
Ask an Expert